Life Extension Center

425 Main Street
Ridgefield, Connecticut 06877
203.431.6165

Research and Publications

Research

Dr. Zabrecky is involved in a significant amount of research to examine the treatment of complex disorders with alternative, complementary and integrative medicine approaches. Some of Dr. Zabrecky's current research interests include:


Dr. Zabrecky holds a patent for "compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis (US7078064)".

The invention relates generally to compositions comprising antioxidants useful for reducing oxidative stress and lipid peroxidation and treating chronic liver disease, chronic hepatitis C virus infection and non-alcoholic steatohepatitis. In particular, the invention relates to the preparation and oral administration of compositions comprising glycyrrhizin, schisandra, ascorbic acid, L-glutathione, silymarin, lipoic acid and d-alpha-tocopherol. The invention also relates to the preparation and parenteral administration of compositions comprising glycyrrhizin, ascorbic acid, L-glutathione and vitamin B-complex, preferably by infusion or intravenous injection. The invention further relates to methods of using the antioxidants, oral compositions and parenteral compositions.

Publications

2007: Gabbay Ezra; Zigmond Ehud; Pappo Orit; Hemed Nila; Rowe Mina; Zabrecky George; Cohen Robert; Ilan Yaron
Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial.
World journal of gastroenterology : WJG 2007;13(40):5317-23.

2007: Ichim Thomas E; Solano Fabio; Glenn Eduardo; Morales Frank; Smith Leonard; Zabrecky George; Riordan Neil H
Stem cell therapy for autism.
Journal of translational medicine 2007;5():30.

2005: Melhem Alla; Stern Mirela; Shibolet Oren; Israeli Eran; Ackerman Zvi; Pappo Orit; Hemed Nilla; Rowe Mina; Ohana Hana; Zabrecky George; Cohen Robert; Ilan Yaron
Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial.
Journal of clinical gastroenterology 2005;39(8):737-42.